<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Muscular dystrophy / Clinical trial / Design of experiments / Pharmacology / Disease registry / Spinal muscular atrophy / TREAT-NMD / Duchenne muscular dystrophy / Medicine / Health / Clinical research
Date: 2015-02-25 01:48:12
Pharmaceutical industry
Muscular dystrophy
Clinical trial
Design of experiments
Pharmacology
Disease registry
Spinal muscular atrophy
TREAT-NMD
Duchenne muscular dystrophy
Medicine
Health
Clinical research

Australian NMD Registry Consent Form Version[removed]

Add to Reading List

Source URL: nmdregistry.com.au

Download Document from Source Website

File Size: 443,53 KB

Share Document on Facebook

Similar Documents

Imperativos para la Distrofia Muscular DuchenneUna guía para los proveedores de la salud  D

Imperativos para la Distrofia Muscular DuchenneUna guía para los proveedores de la salud D

DocID: 1r7YA - View Document

FP7 at Newcastle University Faculty of Medical Sciences CD-MEDICS Coeliac Disease Management Monitoring

FP7 at Newcastle University Faculty of Medical Sciences CD-MEDICS Coeliac Disease Management Monitoring

DocID: 18Ev2 - View Document

Annual Scientific Report.pdf

Annual Scientific Report.pdf

DocID: 14kj7 - View Document

TREAT-NMD in Ukraine  The aim of TREAT-NMD is to improve treatments and find cures for neuromuscular diseases by linking leading clinicians and researchers in a “network of excellence”.

TREAT-NMD in Ukraine  The aim of TREAT-NMD is to improve treatments and find cures for neuromuscular diseases by linking leading clinicians and researchers in a “network of excellence”.

DocID: 13zzM - View Document

1 Регистрационная форма ДСМА/TREAT-NMD Украинский Реестр пациентов со СMA

DocID: 11RE5 - View Document